CG

What Is the Market Outlook on CG?

The Carlyle shares fell -1.0% this morning to a price of $41.05. The stock is still trading within range of its average target price of $39.23, and over the last 52 weeks, it has recorded a 39.4% performance. Analysts have given the large-cap Asset Management stock target prices ranging from $26.0 to $58.0 dollars per share, with an average rating of buy.

The Carlyle has an average level of shares sold short, at 7.7% of its total share float. The stock's short ratio (also called days to cover) is 3.4. The company's insiders own 31.64% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 58.3% of The Carlyle's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in The Carlyle

Date Reported Holder Percentage Shares Value
2023-09-30 Vanguard Group Inc 6% 23,119,999 $949,075,941
2023-09-30 Blackrock Inc. 6% 21,690,040 $890,376,125
2023-09-30 Capital World Investors 6% 19,970,001 $819,768,525
2023-09-30 Morgan Stanley 5% 18,024,935 $739,923,567
2023-09-30 Alkeon Capital Management LLC 3% 11,430,850 $469,236,383
2023-09-30 Vulcan Value Partners, LLC 3% 9,813,179 $402,830,990
2023-09-30 William Blair Investment Management, LLC 2% 8,877,428 $364,418,412
2023-09-30 Ariel Investments, LLC 2% 6,364,528 $261,263,869
2023-09-30 State Street Corporation 1% 5,269,320 $216,305,581
2023-09-30 Beutel, Goodman & Company Ltd 1% 4,335,321 $177,964,923
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS